Dr. Winters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Pl
New York, NY 10029Phone+1 212-659-8551
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Transplant Hepatology, 2021 - 2022
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2018 - 2021
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2015 - 2018
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2015
Certifications & Licensure
- NY State Medical License 2016 - 2025
- CA State Medical License 2018 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Young Physician Leadership Scholar American College of Gastroenterology, 2020
- AASLD Ambassador American Association for the Study of Liver Diseases, 2019
- AASLD Emerging Liver Scholar American Association for the Study of Liver Diseases, 2017
Publications & Presentations
PubMed
- 40 citationsShorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative ColitisDavid Faleck, Adam Winters, Shreya Chablaney, Preeti Shashi, Joseph Meserve
Clinical Gastroenterology and Hepatology. 2019-11-01 - 44 citationsDevelopment and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Joseph Meserve, Adam Winters
Clinical Gastroenterology and Hepatology. 2020-02-13 - 90 citationsDevelopment and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s DiseaseParambir S. Dulai, Brigid S. Boland, Siddharth Singh, Khadija Chaudrey, Jenna L. Koliani-Pace
Gastroenterology. 2018-09-01
Professional Memberships
- Member
- Member
- American Association for the Study of Liver DiseasesMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: